author-photo

Alexandra Bahgat

Memorial Sloan Kettering Cancer Center

2

Papers

22

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

A Phase II, Multicenter Study of High Dose Chemotherapy with Autologous Stem Cell Transplant Followed By Maintenance Therapy with Romidepsin for T-Cell Lymphoma

2019 Blood
Show All
- Source
- Cite
- Save
Citations (2)
The Combination of Duvelisib, a PI3K-δ,γ Inhibitor, and Romidepsin Is Highly Active in Relapsed/Refractory Peripheral T-Cell Lymphoma with Low Rates of Transaminitis: Results of Parallel Multicenter, Phase 1 Combination Studies with Expansion Cohorts

2018 Blood
Show All
- Source
- Cite
- Save
Citations (20)